These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3283176)

  • 1. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
    Calandra GB; Ricci FM; Wang C; Brown KR
    J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open trial of imipenem/cilastatin therapy for serious bacterial infections.
    Brooks RG; McCabe RE; Vosti KL; Remington JS
    Rev Infect Dis; 1985; 7 Suppl 3():S496-505. PubMed ID: 3901213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
    Calandra GB; Hesney M; Grad C
    Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin: general experience in a community hospital.
    Iannini PB; Kunkel MJ; Hilton E; Iannini GM
    Am J Med; 1985 Jun; 78(6A):122-6. PubMed ID: 3859211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.
    Wang C; Calandra GB; Aziz MA; Brown KR
    Rev Infect Dis; 1985; 7 Suppl 3():S528-36. PubMed ID: 3901217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of imipenem/cilastatin on the colonic microflora.
    Nord CE; Kager L; Philipson A; Stiernstedt G
    Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy.
    Wang C; Pappas F; Cook T
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():185-91. PubMed ID: 3469193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR; Hart CB; Shih WJ; Aziz MA
    Scand J Infect Dis Suppl; 1987; 52():56-64. PubMed ID: 3331043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
    Pastel DA
    Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia treated with imipenem/cilastatin.
    Salata RA; Gebhart RL; Palmer DL; Wade BH; Scheld WM; Groschel DH; Wenzel RP; Mandell GL; Duma RJ
    Am J Med; 1985 Jun; 78(6A):104-9. PubMed ID: 3859208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical experience with imipenem-cilistatin.
    Ellis-Pegler RB; Downey D; Bremner DA
    N Z Med J; 1985 Mar; 98(775):188-91. PubMed ID: 3856762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA; Villavicencio J; Ramirez C
    Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.